Skip to main content
. 2023 Mar 28;13(3):e061591. doi: 10.1136/bmjopen-2022-061591

Table 2.

Pharmaceutical company connections in each country measured by common recipients

Network measure* England Scotland Wales Northern Ireland
Density—average value (average number of recipients in common between two companies) 6.71 1.24 1.13 0.42
Density—average weighted degree (average number of recipients in common for all companies in the network) 664.36 88.39 71.06 17.38
Company with highest degree centrality score (number of recipients a company has in common with all other companies in the network) Pfizer (3394) Pfizer (319) Pfizer (206) Pfizer (63)

*Calculations were conducted on valued networks which means they consider the number of common recipients and not just the presence of a shared recipient. Networks include only companies making payments in each country.